scispace - formally typeset
B

Bing Xu

Researcher at Brandeis University

Publications -  373
Citations -  29970

Bing Xu is an academic researcher from Brandeis University. The author has contributed to research in topics: Self-healing hydrogels & Cancer cell. The author has an hindex of 83, co-authored 357 publications receiving 26713 citations. Previous affiliations of Bing Xu include University of Pennsylvania & University of Hong Kong.

Papers
More filters
Journal ArticleDOI

Inspiration from the mirror: D-amino acid containing peptides in biomedical approaches.

TL;DR: Several emerging works on the enzyme-instructed self-assembly (EISA) and their potential application in selective anti-inflammatory or anticancer therapies are described.
Journal ArticleDOI

Enzymatic formation of a photoresponsive supramolecular hydrogel

TL;DR: This paper reports the first example of the use of an enzymatic reaction to generate a photoresponsive hydrogelator, which represents a convenient route to expand the scope of optically controlled molecular self-assembly in water.
Journal ArticleDOI

A proton-doped calix[4]arene-based conducting polymer.

TL;DR: Segmented conducting polymers based upon a calix[4]arene scaffold are reported, which have a segmented structure that imposes greater localization of the carriers and have high conductivity.
Journal ArticleDOI

d-Amino Acids Modulate the Cellular Response of Enzymatic-Instructed Supramolecular Nanofibers of Small Peptides

TL;DR: A new way for tailoring the properties of supramolecular assemblies is illustrated, and new insights are provided to answering the fundamental question of how mammalian cells respond to enzymatic formation of nanoscale supramolescular assemblies (e.g., nanofibers) of d-peptides.
Journal ArticleDOI

Enzyme-Regulated Supramolecular Assemblies of Cholesterol Conjugates against Drug-Resistant Ovarian Cancer Cells.

TL;DR: This work illustrates the integration of enzyme catalysis and self-assembly of essential biological small molecules on and inside cancer cells as a promising strategy for developing multifunctional therapeutics to treat drug-resistant cancers.